diarrhea/edema

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter

TECHNICAL FIELD This invention relates generally to diarylmethyl piperazine and diarylmethyl piperidine compounds having utility as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter function. The compounds of the invention

FIELD OF THE INVENTION The present invention relates to compounds that are A.sub.1 adenosine receptor antagonists, and to their use in treating mammals for various disease states, such as asthma, diabetes, cardiac disorders, degenerative disorders of the central nervous system, and disease states

TECHNICAL FIELD This application relates to a non-pathogenic F18 E. coli strain and to the use thereof. BACKGROUND Edema disease and diarrhea typically are common diseases amongst animals raised by breeders. For example, edema disease in weaned piglets is typically caused by shiga toxin--encoding

TECHNICAL FIELD This application relates to a non-pathogenic F18 E. coli strain and to the use thereof. BACKGROUND Edema disease and diarrhea typically are common diseases amongst animals raised by breeders. For example, edema disease in weaned piglets is typically caused by shiga toxin-encoding

TECHNICAL FIELD This application relates to a non-pathogenic F18 E. coli strain and to the use thereof. BACKGROUND Edema disease and diarrhea typically are common diseases amongst animals raised by breeders. For example, edema disease in weaned piglets is typically caused by shiga toxin-encoding

The invention relates to 5-nitroanthranilic acids of the formula I ##STR2## in which R represents hydrogen or alkyl having 1-4 carbon atoms, X represents a chain (CH.sub.2).sub.n, n being 1, 2, 3 or 4, and the chain being unsubstituted or substituted by 1 to 2n alkyl radicals having 1-2 carbon

FIELD OF THE INVENTION The present invention relates to antibodies to Shiga-like toxins. More particularly, it relates to high titer, monospecific, purified polyclonal antibodies to Shiga-like toxins and methods of preparing and using the antibodies. The invention also relates to the pharmaceutical

BACKGROUND OF THE INVENTION 1. Technical Field This invention relates generally to diarylmethylpiperazine compounds useful as mu and/or delta receptor opioid compounds and pharmaceuticals containing same that may be useful for mediating analgesia, combating drug addiction, alcohol addiction, drug

TECHNICAL FIELD This invention relates to morphinan compounds useful as .mu., .kappa. and/or .delta. receptor opioid compounds and pharmaceuticals containing same that may be useful for mediating analgesia, combating drug addiction, alcohol addiction, drug overdose, mental illness, bladder

TECHNICAL FIELD This invention relates to morphinan compounds useful as .mu., .kappa. and/or .delta. receptor opioid compounds and pharmaceuticals containing same that may be useful for mediating analgesia, combating drug addiction, alcohol addiction, drug overdose, mental illness, bladder